NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services today announced it has acquired the Canadian business of Centogene for an undisclosed amount.
Germany-based Centogene provides genetic testing for inherited diseases and performs testing for a number of genetic centers in Canada. During the next few months, Centogene's test portfolio will be transitioned to Toronto-based LifeLabs, and Centogene's services will continue uninterrupted to clients in Canada, LifeLabs said.
Among the tests offered by Centogene are panels for Aicardi Goutieres syndrome, colon cancer and polyposis syndrome, and Long QT syndrome, according to Centogene's website. LifeLabs added that Centogene also has one of the largest databases of genetic mutations for rare diseases.
"Genetic testing is a significant element of the future of healthcare in Canada," LifeLabs President and CEO Sue Paish said in a statement. "LifeLabs will work with Centogene, healthcare providers, patients, and other stakeholders so that Canadians benefit from this growing and exciting area in an effective and efficient way."